BioCentury | Feb 13, 2021
Product Development

Howdy partner: MD Anderson’s evolving industry collaboration strategy

...Group (Euronext:IPN; Pink:IPSEY) and Navire Pharma Inc. A fourth, MAG-8287, formed the basis of spinout company Magnolia Neurosciences Corp....
BioCentury | Feb 7, 2019
Finance

Pharma ventures earlier

...Last year, the venture arm invested in eight companies, including three preclinical neuroscience companies -- Magnolia Neurosciences Corp....
...Therapeutics Inc., Waltham, Mass. Carisma Therapeutics Inc., Philadelphia, Pa. GlaxoSmithKline plc. (NYSE:GSK; LSE:GSK), London, U.K. Magnolia Neurosciences Corp....
BioCentury | Aug 17, 2018
Finance

MD Anderson’s blooms

...The recent launch of Magnolia Neurosciences Corp. with a $31 million series A round is the latest example...
...is in talks with MD Anderson regarding additional spinouts. Chris Lieu, Staff Writer Accelerator Life Science Partners Alzheimer's disease Magnolia Neurosciences Corp. neuropathy University...
BioCentury | Aug 17, 2018
Financial News

MD Anderson launches neuroscience newco with $31M series A

...of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp....
...and bring a few products into the clinic. Magnolia Neurosciences Corp., New York, N.Y. Chris Lieu Accelerator Life Science Partners Magnolia Neurosciences Corp. University...
BioCentury | Aug 13, 2018
Financial News

MD Anderson launches neuroscience newco with $31M series A

...of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp....
...of concept and bring a few products into the clinic. Chris Lieu Accelerator Life Science Partners Alzheimer's disease (AD) Magnolia Neurosciences Corp....
Items per page:
1 - 5 of 5
BioCentury | Feb 13, 2021
Product Development

Howdy partner: MD Anderson’s evolving industry collaboration strategy

...Group (Euronext:IPN; Pink:IPSEY) and Navire Pharma Inc. A fourth, MAG-8287, formed the basis of spinout company Magnolia Neurosciences Corp....
BioCentury | Feb 7, 2019
Finance

Pharma ventures earlier

...Last year, the venture arm invested in eight companies, including three preclinical neuroscience companies -- Magnolia Neurosciences Corp....
...Therapeutics Inc., Waltham, Mass. Carisma Therapeutics Inc., Philadelphia, Pa. GlaxoSmithKline plc. (NYSE:GSK; LSE:GSK), London, U.K. Magnolia Neurosciences Corp....
BioCentury | Aug 17, 2018
Finance

MD Anderson’s blooms

...The recent launch of Magnolia Neurosciences Corp. with a $31 million series A round is the latest example...
...is in talks with MD Anderson regarding additional spinouts. Chris Lieu, Staff Writer Accelerator Life Science Partners Alzheimer's disease Magnolia Neurosciences Corp. neuropathy University...
BioCentury | Aug 17, 2018
Financial News

MD Anderson launches neuroscience newco with $31M series A

...of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp....
...and bring a few products into the clinic. Magnolia Neurosciences Corp., New York, N.Y. Chris Lieu Accelerator Life Science Partners Magnolia Neurosciences Corp. University...
BioCentury | Aug 13, 2018
Financial News

MD Anderson launches neuroscience newco with $31M series A

...of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp....
...of concept and bring a few products into the clinic. Chris Lieu Accelerator Life Science Partners Alzheimer's disease (AD) Magnolia Neurosciences Corp....
Items per page:
1 - 5 of 5